APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neonatal Immune Cell Storage Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Neonatal Immune Cell Storage Service Market Analysis and Forecast 2026-2032

1 May 2026252 pages

Choose your research edition.

Industry ResearchNeonatal Immune Cell Storage Service Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Neonatal Immune Cell Storage Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Neonatal Immune Cell Storage Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neonatal Immune Cell Storage Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Neonatal Immune Cell Storage Service Market Analysis and Forecast 2026-2032252 pages · $4,950 USD

Market perspective

The global Neonatal Immune Cell Storage Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Neonatal Immune Cell Storage Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neonatal Immune Cell Storage Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neonatal Immune Cell Storage Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neonatal Immune Cell Storage Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Neonatal Immune Cell Storage Service include Shanghai Cell Therapy Group, BGI Group, VCANBIO, CGT GLOBAL, Cordlife Group, ThermoGenesis, HealthBanks, BioLife Solutions and Sartorius, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Neonatal Immune Cell Storage Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neonatal Immune Cell Storage Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Neonatal Immune Cell Storage Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neonatal Immune Cell Storage Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neonatal Immune Cell Storage Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Neonatal Immune Cell Storage Service revenue, projected growth trends, production technology, application and end-user industry.

Neonatal Immune Cell Storage Service Segment by Company

Shanghai Cell Therapy Group

BGI Group

VCANBIO

CGT GLOBAL

Cordlife Group

ThermoGenesis

HealthBanks

BioLife Solutions

Sartorius

CGT GLOBAL

Cordlife Group

Aeterna Health

Cell Vault

Redermis

Innovita Research

Neonatal Immune Cell Storage Service Segment by Type

100ml Blood Collection Volume

150ml Blood Collection Volume

200ml Blood Collection Volume

Neonatal Immune Cell Storage Service Segment by Application

Personal

Commercial

Neonatal Immune Cell Storage Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neonatal Immune Cell Storage Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neonatal Immune Cell Storage Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neonatal Immune Cell Storage Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Neonatal Immune Cell Storage Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Neonatal Immune Cell Storage Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neonatal Immune Cell Storage Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neonatal Immune Cell Storage Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100ml Blood Collection Volume Major Player Table 3. 150ml Blood Collection Volume Major Player Table 4. 200ml Blood Collection Volume Major Player Table 5. Global Neonatal Immune Cell Storage Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Personal Major Player Table 7. Commercial Major Player Table 8. Neonatal Immune Cell Storage Service Industry Trends Table 9. Neonatal Immune Cell Storage Service Industry Drivers Table 10. Neonatal Immune Cell Storage Service Industry Opportunities and Challenges Table 11. Neonatal Immune Cell Storage Service Industry Restraints Table 12. Global Neonatal Immune Cell Storage Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Neonatal Immune Cell Storage Service Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Neonatal Immune Cell Storage Service Market Share by Region (2021-2026) Table 15. Global Neonatal Immune Cell Storage Service Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Neonatal Immune Cell Storage Service Market Share by Region (2027-2032) Table 17. Global Neonatal Immune Cell Storage Service Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Neonatal Immune Cell Storage Service Revenue Market Share by Players (2021-2026) Table 19. Global Neonatal Immune Cell Storage Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Neonatal Immune Cell Storage Service Key Players Headquarters & Area Served Table 21. Global Neonatal Immune Cell Storage Service Players, Product Type & Application Table 22. Global Neonatal Immune Cell Storage Service Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Neonatal Immune Cell Storage Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Neonatal Immune Cell Storage Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Neonatal Immune Cell Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Neonatal Immune Cell Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Neonatal Immune Cell Storage Service Revenue Market Share by Type (2021-2026) Table 29. Global Neonatal Immune Cell Storage Service Revenue Market Share by Type (2027-2032) Table 30. Global Neonatal Immune Cell Storage Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Neonatal Immune Cell Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Neonatal Immune Cell Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Neonatal Immune Cell Storage Service Revenue Market Share by Application (2021-2026) Table 34. Global Neonatal Immune Cell Storage Service Revenue Market Share by Application (2027-2032) Table 35. Shanghai Cell Therapy Group Company Information Table 36. Shanghai Cell Therapy Group Business Overview Table 37. Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Product Portfolio Table 39. Shanghai Cell Therapy Group Recent Development Table 40. BGI Group Company Information Table 41. BGI Group Business Overview Table 42. BGI Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. BGI Group Neonatal Immune Cell Storage Service Product Portfolio Table 44. BGI Group Recent Development Table 45. VCANBIO Company Information Table 46. VCANBIO Business Overview Table 47. VCANBIO Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. VCANBIO Neonatal Immune Cell Storage Service Product Portfolio Table 49. VCANBIO Recent Development Table 50. CGT GLOBAL Company Information Table 51. CGT GLOBAL Business Overview Table 52. CGT GLOBAL Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio Table 54. CGT GLOBAL Recent Development Table 55. Cordlife Group Company Information Table 56. Cordlife Group Business Overview Table 57. Cordlife Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio Table 59. Cordlife Group Recent Development Table 60. ThermoGenesis Company Information Table 61. ThermoGenesis Business Overview Table 62. ThermoGenesis Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. ThermoGenesis Neonatal Immune Cell Storage Service Product Portfolio Table 64. ThermoGenesis Recent Development Table 65. HealthBanks Company Information Table 66. HealthBanks Business Overview Table 67. HealthBanks Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. HealthBanks Neonatal Immune Cell Storage Service Product Portfolio Table 69. HealthBanks Recent Development Table 70. BioLife Solutions Company Information Table 71. BioLife Solutions Business Overview Table 72. BioLife Solutions Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. BioLife Solutions Neonatal Immune Cell Storage Service Product Portfolio Table 74. BioLife Solutions Recent Development Table 75. Sartorius Company Information Table 76. Sartorius Business Overview Table 77. Sartorius Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Sartorius Neonatal Immune Cell Storage Service Product Portfolio Table 79. Sartorius Recent Development Table 80. CGT GLOBAL Company Information Table 81. CGT GLOBAL Business Overview Table 82. CGT GLOBAL Neonatal Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio Table 84. CGT GLOBAL Recent Development Table 85. Cordlife Group Company Information Table 86. Cordlife Group Business Overview Table 87. Cordlife Group Neonatal Immune Cell Storage Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio Table 89. Cordlife Group Recent Development Table 90. Aeterna Health Company Information Table 91. Aeterna Health Business Overview Table 92. Aeterna Health Neonatal Immune Cell Storage Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Aeterna Health Neonatal Immune Cell Storage Service Product Portfolio Table 94. Aeterna Health Recent Development Table 95. Cell Vault Company Information Table 96. Cell Vault Business Overview Table 97. Cell Vault Neonatal Immune Cell Storage Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Cell Vault Neonatal Immune Cell Storage Service Product Portfolio Table 99. Cell Vault Recent Development Table 100. Redermis Company Information Table 101. Redermis Business Overview Table 102. Redermis Neonatal Immune Cell Storage Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Redermis Neonatal Immune Cell Storage Service Product Portfolio Table 104. Redermis Recent Development Table 105. Innovita Research Company Information Table 106. Innovita Research Business Overview Table 107. Innovita Research Neonatal Immune Cell Storage Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Innovita Research Neonatal Immune Cell Storage Service Product Portfolio Table 109. Innovita Research Recent Development Table 110. North America Neonatal Immune Cell Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 111. North America Neonatal Immune Cell Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 112. North America Neonatal Immune Cell Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Neonatal Immune Cell Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Neonatal Immune Cell Storage Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Neonatal Immune Cell Storage Service Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Neonatal Immune Cell Storage Service Revenue by Country (US$ Million) & (2027-2032) Table 117. Europe Neonatal Immune Cell Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Neonatal Immune Cell Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Neonatal Immune Cell Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Neonatal Immune Cell Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Neonatal Immune Cell Storage Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Neonatal Immune Cell Storage Service Revenue by Country (2021-2026) & (US$ Million) Table 123. Europe Neonatal Immune Cell Storage Service Revenue by Country (US$ Million) & (2027-2032) Table 124. China Neonatal Immune Cell Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 125. China Neonatal Immune Cell Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 126. China Neonatal Immune Cell Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 127. China Neonatal Immune Cell Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Neonatal Immune Cell Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Neonatal Immune Cell Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Neonatal Immune Cell Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 131. Asia Neonatal Immune Cell Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Neonatal Immune Cell Storage Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Neonatal Immune Cell Storage Service Revenue by Region (US$ Million) & (2021-2026) Table 134. Asia Neonatal Immune Cell Storage Service Revenue by Region (US$ Million) & (2027-2032) Table 135. SAMEA Neonatal Immune Cell Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 136. SAMEA Neonatal Immune Cell Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 137. SAMEA Neonatal Immune Cell Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 138. SAMEA Neonatal Immune Cell Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 139. SAMEA Neonatal Immune Cell Storage Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. SAMEA Neonatal Immune Cell Storage Service Revenue by Country (2021-2026) & (US$ Million) Table 141. SAMEA Neonatal Immune Cell Storage Service Revenue by Country (US$ Million) & (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Neonatal Immune Cell Storage Service Image Figure 2. Global Neonatal Immune Cell Storage Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neonatal Immune Cell Storage Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100ml Blood Collection Volume Image Figure 5. 150ml Blood Collection Volume Image Figure 6. 200ml Blood Collection Volume Image Figure 7. Global Neonatal Immune Cell Storage Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Neonatal Immune Cell Storage Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Personal Image Figure 10. Commercial Image Figure 11. Global Neonatal Immune Cell Storage Service Market Size (US$ Million) & (2021-2032) Figure 12. Global Neonatal Immune Cell Storage Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Neonatal Immune Cell Storage Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Neonatal Immune Cell Storage Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Neonatal Immune Cell Storage Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Neonatal Immune Cell Storage Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Neonatal Immune Cell Storage Service Revenue Market Share by Type (2021-2032) Figure 19. Global Neonatal Immune Cell Storage Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Neonatal Immune Cell Storage Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Neonatal Immune Cell Storage Service Revenue Market Share by Application (2021-2032) Figure 22. North America Neonatal Immune Cell Storage Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Neonatal Immune Cell Storage Service Revenue Share by Type (2021-2032) Figure 24. North America Neonatal Immune Cell Storage Service Revenue Share by Application (2021-2032) Figure 25. North America Neonatal Immune Cell Storage Service Revenue Share by Country (2021-2032) Figure 26. United States Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Neonatal Immune Cell Storage Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Neonatal Immune Cell Storage Service Revenue Share by Type (2021-2032) Figure 31. Europe Neonatal Immune Cell Storage Service Revenue Share by Application (2021-2032) Figure 32. Europe Neonatal Immune Cell Storage Service Revenue Share by Country (2021-2032) Figure 33. Germany Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Neonatal Immune Cell Storage Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Neonatal Immune Cell Storage Service Revenue Share by Type (2021-2032) Figure 43. China Neonatal Immune Cell Storage Service Revenue Share by Application (2021-2032) Figure 44. Asia Neonatal Immune Cell Storage Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Neonatal Immune Cell Storage Service Revenue Share by Type (2021-2032) Figure 46. Asia Neonatal Immune Cell Storage Service Revenue Share by Application (2021-2032) Figure 47. Asia Neonatal Immune Cell Storage Service Revenue Share by Region (2021-2032) Figure 48. Japan Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Neonatal Immune Cell Storage Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Neonatal Immune Cell Storage Service Revenue Share by Type (2021-2032) Figure 56. SAMEA Neonatal Immune Cell Storage Service Revenue Share by Application (2021-2032) Figure 57. SAMEA Neonatal Immune Cell Storage Service Revenue Share by Country (2021-2032) Figure 58. Brazil Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Neonatal Immune Cell Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 100ml Blood Collection Volume
  • 150ml Blood Collection Volume
  • 200ml Blood Collection Volume
Applications
  • Personal
  • Commercial
Companies covered
  • Shanghai Cell Therapy Group
  • BGI Group
  • VCANBIO
  • CGT GLOBAL
  • Cordlife Group
  • ThermoGenesis
  • HealthBanks
  • BioLife Solutions
  • Sartorius
  • CGT GLOBAL
  • Cordlife Group
  • Aeterna Health
  • Cell Vault
  • Redermis
  • Innovita Research

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neonatal Immune Cell Storage Service Market by Type
  3. 1.2.1 Global Neonatal Immune Cell Storage Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100ml Blood Collection Volume
  5. 1.2.3 150ml Blood Collection Volume
  6. 1.2.4 200ml Blood Collection Volume
  7. 1.3 Neonatal Immune Cell Storage Service Market by Application
  8. 1.3.1 Global Neonatal Immune Cell Storage Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Personal
  10. 1.3.3 Commercial
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Neonatal Immune Cell Storage Service Market Dynamics
  1. 2.1 Neonatal Immune Cell Storage Service Industry Trends
  2. 2.2 Neonatal Immune Cell Storage Service Industry Drivers
  3. 2.3 Neonatal Immune Cell Storage Service Industry Opportunities and Challenges
  4. 2.4 Neonatal Immune Cell Storage Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Neonatal Immune Cell Storage Service Market Perspective (2021-2032)
  2. 3.2 Global Neonatal Immune Cell Storage Service Growth Trends by Region
  3. 3.2.1 Global Neonatal Immune Cell Storage Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neonatal Immune Cell Storage Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Neonatal Immune Cell Storage Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Neonatal Immune Cell Storage Service Revenue by Players
  2. 4.1.1 Global Neonatal Immune Cell Storage Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Neonatal Immune Cell Storage Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Neonatal Immune Cell Storage Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neonatal Immune Cell Storage Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Neonatal Immune Cell Storage Service Key Players Headquarters & Area Served
  7. 4.4 Global Neonatal Immune Cell Storage Service Players, Product Type & Application
  8. 4.5 Global Neonatal Immune Cell Storage Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Neonatal Immune Cell Storage Service Market CR5 and HHI
  11. 4.6.3 2025 Neonatal Immune Cell Storage Service Tier 1, Tier 2, and Tier 3
5 Neonatal Immune Cell Storage Service Market Size by Type
  1. 5.1 Global Neonatal Immune Cell Storage Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Neonatal Immune Cell Storage Service Revenue by Type (2021-2032)
  3. 5.3 Global Neonatal Immune Cell Storage Service Revenue Market Share by Type (2021-2032)
6 Neonatal Immune Cell Storage Service Market Size by Application
  1. 6.1 Global Neonatal Immune Cell Storage Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Neonatal Immune Cell Storage Service Revenue by Application (2021-2032)
  3. 6.3 Global Neonatal Immune Cell Storage Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Shanghai Cell Therapy Group
  2. 7.1.1 Shanghai Cell Therapy Group Company Information
  3. 7.1.2 Shanghai Cell Therapy Group Business Overview
  4. 7.1.3 Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Product Portfolio
  6. 7.1.5 Shanghai Cell Therapy Group Recent Developments
  7. 7.2 BGI Group
  8. 7.2.1 BGI Group Company Information
  9. 7.2.2 BGI Group Business Overview
  10. 7.2.3 BGI Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BGI Group Neonatal Immune Cell Storage Service Product Portfolio
  12. 7.2.5 BGI Group Recent Developments
  13. 7.3 VCANBIO
  14. 7.3.1 VCANBIO Company Information
  15. 7.3.2 VCANBIO Business Overview
  16. 7.3.3 VCANBIO Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 VCANBIO Neonatal Immune Cell Storage Service Product Portfolio
  18. 7.3.5 VCANBIO Recent Developments
  19. 7.4 CGT GLOBAL
  20. 7.4.1 CGT GLOBAL Company Information
  21. 7.4.2 CGT GLOBAL Business Overview
  22. 7.4.3 CGT GLOBAL Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio
  24. 7.4.5 CGT GLOBAL Recent Developments
  25. 7.5 Cordlife Group
  26. 7.5.1 Cordlife Group Company Information
  27. 7.5.2 Cordlife Group Business Overview
  28. 7.5.3 Cordlife Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio
  30. 7.5.5 Cordlife Group Recent Developments
  31. 7.6 ThermoGenesis
  32. 7.6.1 ThermoGenesis Company Information
  33. 7.6.2 ThermoGenesis Business Overview
  34. 7.6.3 ThermoGenesis Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ThermoGenesis Neonatal Immune Cell Storage Service Product Portfolio
  36. 7.6.5 ThermoGenesis Recent Developments
  37. 7.7 HealthBanks
  38. 7.7.1 HealthBanks Company Information
  39. 7.7.2 HealthBanks Business Overview
  40. 7.7.3 HealthBanks Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 HealthBanks Neonatal Immune Cell Storage Service Product Portfolio
  42. 7.7.5 HealthBanks Recent Developments
  43. 7.8 BioLife Solutions
  44. 7.8.1 BioLife Solutions Company Information
  45. 7.8.2 BioLife Solutions Business Overview
  46. 7.8.3 BioLife Solutions Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BioLife Solutions Neonatal Immune Cell Storage Service Product Portfolio
  48. 7.8.5 BioLife Solutions Recent Developments
  49. 7.9 Sartorius
  50. 7.9.1 Sartorius Company Information
  51. 7.9.2 Sartorius Business Overview
  52. 7.9.3 Sartorius Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sartorius Neonatal Immune Cell Storage Service Product Portfolio
  54. 7.9.5 Sartorius Recent Developments
  55. 7.10 CGT GLOBAL
  56. 7.10.1 CGT GLOBAL Company Information
  57. 7.10.2 CGT GLOBAL Business Overview
  58. 7.10.3 CGT GLOBAL Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio
  60. 7.10.5 CGT GLOBAL Recent Developments
  61. 7.11 Cordlife Group
  62. 7.11.1 Cordlife Group Company Information
  63. 7.11.2 Cordlife Group Business Overview
  64. 7.11.3 Cordlife Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio
  66. 7.11.5 Cordlife Group Recent Developments
  67. 7.12 Aeterna Health
  68. 7.12.1 Aeterna Health Company Information
  69. 7.12.2 Aeterna Health Business Overview
  70. 7.12.3 Aeterna Health Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Aeterna Health Neonatal Immune Cell Storage Service Product Portfolio
  72. 7.12.5 Aeterna Health Recent Developments
  73. 7.13 Cell Vault
  74. 7.13.1 Cell Vault Company Information
  75. 7.13.2 Cell Vault Business Overview
  76. 7.13.3 Cell Vault Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cell Vault Neonatal Immune Cell Storage Service Product Portfolio
  78. 7.13.5 Cell Vault Recent Developments
  79. 7.14 Redermis
  80. 7.14.1 Redermis Company Information
  81. 7.14.2 Redermis Business Overview
  82. 7.14.3 Redermis Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Redermis Neonatal Immune Cell Storage Service Product Portfolio
  84. 7.14.5 Redermis Recent Developments
  85. 7.15 Innovita Research
  86. 7.15.1 Innovita Research Company Information
  87. 7.15.2 Innovita Research Business Overview
  88. 7.15.3 Innovita Research Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Innovita Research Neonatal Immune Cell Storage Service Product Portfolio
  90. 7.15.5 Innovita Research Recent Developments
8 North America
  1. 8.1 North America Neonatal Immune Cell Storage Service Revenue (2021-2032)
  2. 8.2 North America Neonatal Immune Cell Storage Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Neonatal Immune Cell Storage Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Neonatal Immune Cell Storage Service Revenue by Type (2027-2032)
  5. 8.3 North America Neonatal Immune Cell Storage Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Neonatal Immune Cell Storage Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Neonatal Immune Cell Storage Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Neonatal Immune Cell Storage Service Revenue by Application (2027-2032)
  9. 8.5 North America Neonatal Immune Cell Storage Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Neonatal Immune Cell Storage Service Revenue by Country
  11. 8.6.1 North America Neonatal Immune Cell Storage Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Neonatal Immune Cell Storage Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Neonatal Immune Cell Storage Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Neonatal Immune Cell Storage Service Revenue (2021-2032)
  2. 9.2 Europe Neonatal Immune Cell Storage Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Neonatal Immune Cell Storage Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Neonatal Immune Cell Storage Service Revenue by Type (2027-2032)
  5. 9.3 Europe Neonatal Immune Cell Storage Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Neonatal Immune Cell Storage Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Neonatal Immune Cell Storage Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Neonatal Immune Cell Storage Service Revenue by Application (2027-2032)
  9. 9.5 Europe Neonatal Immune Cell Storage Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Neonatal Immune Cell Storage Service Revenue by Country
  11. 9.6.1 Europe Neonatal Immune Cell Storage Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Neonatal Immune Cell Storage Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Neonatal Immune Cell Storage Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Neonatal Immune Cell Storage Service Revenue (2021-2032)
  2. 10.2 China Neonatal Immune Cell Storage Service Revenue by Type (2021-2032)
  3. 10.2.1 China Neonatal Immune Cell Storage Service Revenue by Type (2021-2026)
  4. 10.2.2 China Neonatal Immune Cell Storage Service Revenue by Type (2027-2032)
  5. 10.3 China Neonatal Immune Cell Storage Service Revenue Share by Type (2021-2032)
  6. 10.4 China Neonatal Immune Cell Storage Service Revenue by Application (2021-2032)
  7. 10.4.1 China Neonatal Immune Cell Storage Service Revenue by Application (2021-2026)
  8. 10.4.2 China Neonatal Immune Cell Storage Service Revenue by Application (2027-2032)
  9. 10.5 China Neonatal Immune Cell Storage Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neonatal Immune Cell Storage Service Revenue (2021-2032)
  2. 11.2 Asia Neonatal Immune Cell Storage Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Neonatal Immune Cell Storage Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Neonatal Immune Cell Storage Service Revenue by Type (2027-2032)
  5. 11.3 Asia Neonatal Immune Cell Storage Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Neonatal Immune Cell Storage Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Neonatal Immune Cell Storage Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Neonatal Immune Cell Storage Service Revenue by Application (2027-2032)
  9. 11.5 Asia Neonatal Immune Cell Storage Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Neonatal Immune Cell Storage Service Revenue by Country
  11. 11.6.1 Asia Neonatal Immune Cell Storage Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Neonatal Immune Cell Storage Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Neonatal Immune Cell Storage Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neonatal Immune Cell Storage Service Revenue (2021-2032)
  2. 12.2 SAMEA Neonatal Immune Cell Storage Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Neonatal Immune Cell Storage Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Neonatal Immune Cell Storage Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Neonatal Immune Cell Storage Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Neonatal Immune Cell Storage Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Neonatal Immune Cell Storage Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Neonatal Immune Cell Storage Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Neonatal Immune Cell Storage Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Neonatal Immune Cell Storage Service Revenue by Country
  11. 12.6.1 SAMEA Neonatal Immune Cell Storage Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Neonatal Immune Cell Storage Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Neonatal Immune Cell Storage Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst